This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Molecular profiling as a novel tool to predict response to interferon‐α2 in MPNs: The proof of concept in early myelofibrosis. Issue 14 (18th May 2017)
Record Type:
Journal Article
Title:
Molecular profiling as a novel tool to predict response to interferon‐α2 in MPNs: The proof of concept in early myelofibrosis. Issue 14 (18th May 2017)
Main Title:
Molecular profiling as a novel tool to predict response to interferon‐α2 in MPNs: The proof of concept in early myelofibrosis
Abstract : High‐risk mutations are associated with poor response to interferon‐α2. Early treatment with interferon‐α2 is recommended in patients who have early myelofibrosis without high‐risk mutations. See also pages 2680‐7.